Ticker: BSPM, Company: Biostar Pharmaceuticals, Inc., Type: 8-K, Date: 2009-04-07
Original SEC Filing: Click here

---

Webplus: BSPM/20090407/8-K/2_EX-99.1/000.htm SEC Original: ex99-1.htm
Biostar Pharmaceuticals, Inc. Reports Record Revenues and Earnings For 2008 Sales Up 118% to $33 Million, Net Income Increased 69% to $6.7 Million Over Prior Year New York, New York – April 7, 2009 – Biostar Pharmaceuticals, Inc. (“Biostar” or the “Company”) (OTCBB: BSPM) today reported financial results for the 12 months ended December 31, 2008. Highlights for Year Ended

---

---

Webplus: BSPM/20090407/8-K/1/000.htm SEC Original: biostar8k040709.htm
FORM 8-K CURRENT REPORT April 7, 2009 Date of Report (Date of earliest event reported): BIOSTAR PHARMACEUTICALS, INC. Maryland 333-147363 20-5101287 (State or other jurisdiction of incorporation) (Commission (IRS Employer Identification No.) Province, The People’s Republic of China No. 588 Shiji Avenue, Xiangyang City, Shaanxi 712046 (Zip Code) 86- 029-33686638 Benjamin Tan, Esq. Sichenzia Ross Friedman Ference LLP 61 Broadway,

---

Company Information:

Ticker: BSPM, Company: Biostar Pharmaceuticals, Inc., Type: 8-K, Date: 2009-04-07CIK: 0001418133, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
NO. 588 SHIJI XI AVENUE
XIANYANG, SHAANXI PROVINCE 712046